We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSNYW icon
1326
Polestar Automotive Holding ADS Class C-1
PSNYW
$358M
– –
-551
Closed -$2.38K
P
1327
Everpure Inc
P
$33.6B
– –
-16,603
Closed -$956K
PWOD
1328
DELISTED
Penns Woods Bancorp
PWOD
– –
-90,917
Closed -$2.76M
QCOM icon
1329
Qualcomm
QCOM
$174B
– –
-1,756
Closed -$280K
RACE icon
1330
Ferrari
RACE
$71.2B
– –
-496
Closed -$243K
RARE icon
1331
Ultragenyx Pharmaceutical
RARE
$2.54B
– –
-12,681
Closed -$461K
RCAT icon
1332
Red Cat Holdings
RCAT
$1.48B
– –
-45,000
Closed -$328K
RDFN
1333
DELISTED
Redfin
RDFN
– –
-327,728
Closed -$3.67M
RDUS
1334
DELISTED
Radius Recycling
RDUS
– –
-89,840
Closed -$2.67M
REAL icon
1335
The RealReal
REAL
$1.49B
– –
-13,552
Closed -$64.9K
REGN icon
1336
Regeneron Pharmaceuticals
REGN
$81.9B
– –
-493
Closed -$259K
RGNX icon
1337
Regenxbio
RGNX
$686M
– –
-82,321
Closed -$676K
RL icon
1338
Ralph Lauren
RL
$23.7B
– –
-1,302
Closed -$357K
RNW icon
1339
ReNew
RNW
$2.24B
– –
-16,064
Closed -$111K
ROST icon
1340
Ross Stores
ROST
$81.8B
– –
-2,636
Closed -$336K
RPRX icon
1341
Royalty Pharma
RPRX
$25.6B
– –
-26,812
Closed -$966K
RSG icon
1342
Republic Services
RSG
$65.7B
– –
-1,056
Closed -$260K
S icon
1343
SentinelOne
S
$7.57B
– –
-14,600
Closed -$267K
SABR icon
1344
Sabre
SABR
$827M
– –
-94,323
Closed -$298K
SAGE
1345
DELISTED
Sage Therapeutics
SAGE
– –
-12,229
Closed -$112K
SAIC icon
1346
Saic
SAIC
$5.36B
– –
-1,970
Closed -$222K
SBH icon
1347
Sally Beauty Holdings
SBH
$1.55B
– –
-21,299
Closed -$197K
SCHW
1348
Charles Schwab
SCHW
$188B
– –
-2,963
Closed -$270K
SE icon
1349
PUT
Sea Limited
SE
$70.3B
– –
-195
Closed -$213K
SENEA icon
1350
Seneca Foods Class A
SENEA
$1.21B
– –
-2,150
Closed -$218K
52 53
54
55 56

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.